The Drug Discovery World Podcast

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a nanoparticle vaccine showed potential to protect from a 'tripledemic'. Elsewhere, could 'magic mushrooms' treat anorexia?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, experts warned patients were being denied access to personalised cancer care. Cancer research was a theme elsewhere, with findings emerging from studies into a CAR T-cell therapy, lung cancer and breast cancer.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Suzanne Caruso, President of Strategic Intelligence and Clinical & Regulatory at Norstella. Norstella supports drug developers looking to take their treatments from pipeline to patients, finding solutions to complexities in the drug development timeline. One of these solutions is AI.

Suzanne discusses what it means for a company to be 'AI-native', how the combination of AI and Real World Data is transforming clinical development, and how AI is enabling companies to get treatments to patients faster.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, researchers uncovered clues explaining risks of heart disease, lung disease, Covid-19 and cancer. Elsewhere, find out what is included in the latest issue of DDW.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, results showed the new Wegovy pill could help patients lose 17% of their body weight. Elsewhere, advances were made in both cancer treatment and cancer research.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Vincent Marion, Scientific Founder and President of AdipoPharma. AdipoPharma is a biotech leveraging research on insulin resistance and adipose tissue biology, developing a new treatment for metabolic diseases.

Vincent discusses what makes AdipoPharma's lead asset different from GLP-1s, why findings into fat tissue dysfunction have been less explored in drug development, and how AdipoPharma is competing in an industry where GLP-1s are becoming increasingly accessible.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, new research showed anti-IL-1β drugs could prevent lung cancer. Elsewhere, the UK is set to benefit from specialised blood tests and funding for early-career researchers.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a cancer drug demonstrated it could reduce tumours by as much as 55%. Elsewhere, AI was a recurrent theme in both clinical trials and drug development.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Terry Connolly and Shinta Cheng from K36 Therapeutics. K36 is a company developing first-in-class cancer therapeutics and their current lead asset is a treatment for multiple myeloma patients.

Bruno speaks to Terry and Shinta about how their NSD2 inhibitors can treat cancer, how their approach compares to other biotechs, and why K36's science could be applied to other therapeutic areas.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a UK group accelerated efforts to develop a vaccine for Ebolavirus. Elsewhere, significant findings in colorectal and brain cancer could shape future cancer treatments.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a report showed patients in Europe face barriers to patient access. Elsewhere, Wellcome prizes are facilitating research in both tropical disease and mental health.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW 'In Conversation With' series is available to listen to now.

This week, Bruno Quinney speaks to Dr Juliana Maynard, Head of Translational Imaging at Medicines Discovery Catapult. MDC recently announced a partnership with the UK National Nuclear Lab, and Maynard's work is at the forefront of advances being made in radiopharmaceuticals.

Bruno speaks to Juliana about investment in the radiopharmaceuticals industry, why radiopharmaceuticals are an exciting approach in the cancer treatment space, and what it would mean for patients if the UK becomes a radiopharma leader.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, research uncovered new treatment pathways for hard to treat breast cancers. Elsewhere, therapies given the green light could combat type 2 diabetes and generalised myasthenia gravis.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, the FDA advanced an initiative to implement real-time clinical trials. Elsewhere, UCB made headlines through an acquisition and its cancer research venture.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Anthony Johnson and Matthew Fyfe from Outrun Therapeutics. Outrun is a biotech specialising in protein stabilisation, an approach being applied to treat HPV+ head and neck cancer.

But what does protein stabilisation mean in practice? And what impact could the approach have for cancer patients?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, the UK made headlines for both the investment it has attracted and the clinical trial reforms it rolled out. Elsewhere, the world's first antimalarial drug for newborns could soon address a critical unmet need.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, an obesity drug proved it could improve liver health independent of weight loss. Elsewhere, Lilly was back in the news for both its type 2 diabetes drug and the company's latest acquisition.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Angus Sinclair, Chief Scientific Officer at LabGenius Therapeutics. LabGenius is a biotech using AI and robotics to design new cancer therapies, and in vivo efficacy data reveals the company's novel T-cell engager shows complete tumour elimination in mice.

Bruno talks to Angus about what T-cell engagers actually are, how AI is driving the company's approach, and why non-intuitive protein design is emerging within immuno-oncology drug development.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, key breakthroughs emerged in cancer research. Elsewhere, regulatory reforms have accelerated clinical trial set up in the UK.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, researchers discovered how genetic mutations cause a previously unknown recessive condition. Elsewhere, Eli Lilly made the headlines for both an approved drug and a drug collaboration.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Robert Albarano and Kristina Capiak from Arthur D Little, who have experience maximising commercial success of drug discovery portfolios and securing FDA designations.

Bruno spoke to Robert and Kristina about the challenges of the regulatory landscape, the global implications of faster FDA approvals, and whether personalised medicines are set to become a key area for investment.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, there were crucial developments in neuroscience drug discovery. Elsewhere, a new treatment for platinum-resistant epithelial ovarian cancer has been approved in the US.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW Narrated Podcast. The episode covers two articles written for DDW Volume 25, Issue 2, Spring 2024.

The first article is called 'Why more work is needed to fight antimicrobial resistance'. In the article, DDW Editor Reece Armstrong speaks to Professor Janet Hemingway CBE about current efforts in tackling antimicrobial resistance.

The second article is called 'The future outlook for mRNA therapies'. In the piece, Reece Armstrong explores the potential opportunities for mRNA-based therapies. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates the key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a study found obesity could be treated in other ways than through drugs suppressing appetite. Elsewhere, prostate cancer was a central theme in cancer research.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates the key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a cancer enzyme discovery provided clues for potential new treatments. Elsewhere, how can your recycled plastic bottles be made into Parkinson's drugs?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, research on the brain proved a popular theme, unlocking insights into Alzheimer's, dementia and cancer. Elsewhere, a genetic target could provide new routes to breast cancer treatment.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, figures showed the number of women in biotech leadership has stalled. Elsewhere, could your diet make cancer therapy more effective?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW 'In Conversation With' series is available to listen to below.

This week, Bruno Quinney speaks to Amir Hefni, CEO of Resolution Therapeutics. Resolution specialises in developing therapies for inflammatory and fibrotic diseases and is currently progressing a treatment for end-stage liver disease through clinical trial.

Bruno spoke to Amir about how Resolution's therapy is addressing a critical unmet need and how long it could be before we see it available to patients.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, more effective treatments were found for both HIV and chronic wounds. Elsewhere, €40,000 is up for grabs in prostate cancer research.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, researchers found an unexpected drug could help treat depression. Elsewhere, a new company is set to advance a cerebral palsy therapy.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, researchers made a key discovery into cancer survival. Elsewhere, a global research effort into kidney disease is underway.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, innovative therapies showed the way to more effective cancer treatments. Elsewhere, how can brain function be improved in Alzheimer's patients?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW podcast is available to listen to below.

This week, Bruno Quinney speaks to DDW Editor Reece Armstrong and Senior Digital Content Editor Diana Turner to look ahead to the world of drug discovery, pharma and biotech in 2026.

They explore why AI will continue to dominate in 2026, why obesity and breast cancer will attract investor attention, and how drug discovery will look to resolve the challenges of clinical trials.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week's discoveries into Parkinson's disease, allergies and common cancers could shape drug development. Elsewhere, why is the UK leading Europe's biotech market?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, an innovative therapy showed encouraging results in tackling melanoma. Elsewhere, why is a former American football player getting involved with a biopharmaceutical company?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, new research in women's health uncovered significant findings related to endometriosis and ovarian cancer. Elsewhere, can ageing be reversed?

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW Narrated Podcast. The episode covers two articles written for DDW Volume 25, Issue 2, Spring 2024.

The first article is called 'Machine learning: developing next generation antibody therapeutics'. Ben Holland, CTO and Co-Founder of Antiverse, discusses how artificial intelligence and machine learning are benefitting antibody discovery and design.

The second article is called 'The next generation of AI'. In the piece, DDW Editor Reece Armstrong speaks to Sean McClain, Founder & CEO of Absci, about the rise of generative AI in life sciences.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a new report found breast cancer was the world's most studied disease for the fifth year running. That same report predicted obesity to break into the top five, with weight loss a key theme across other headlines last week.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a research team found that a hidden molecular switch fuels obesity. Elsewhere, AI-generated antibodies have been tolerated by human immune cells.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, innovative treatments showed potential to treat neurodegenerative diseases, allergies and arthritis. Elsewhere, a study showed China is becoming the dominant force in the biotech sector.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, a trade agreement between the UK and the US promised to support the life sciences industry and secure access to drugs. Elsewhere, novel therapies could break new ground in treating neurodegenerative diseases.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, gene therapies provided solutions for complex conditions, most notably in Hunter syndrome but also in amyotrophic lateral sclerosis (ALS). Elsewhere, research showed antibody-drug conjugate precision therapy could prevent breast cancer.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Bruno Quinney talks to Dr Mrinal Kammili, Head of Translational and Clinical Research at Syngene International. They explore advances in translational science, the challenges of the field, and how India is becoming the next clinical research destination.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, research into bacterial species and diseases broke new ground. Elsewhere, vaccines could offer groundbreaking solutions to cervical and lung cancer.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, groundbreaking research showed the Covid-19 mRNA vaccine could boost cancer response. Elsewhere, the theme of UK investment dominated other headlines.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW Narrated Podcast, called "How new scientific approaches are accelerating R&D". The episode covers two articles written for DDW Volume 25, Issue 1, Winter 2023/24.

The first article is called 'Accelerating recombinant protein vaccine discovery'. In the article, Jian He, Chemistry, Manufacturing and Controls (CMC) Head at WuXi Vaccines, explains why vaccination responses need to be rapid, efficacious and cost-effective if they are to outpace new viral threats emerging across the globe. The second article is called 'How 3D biology is informing drug discovery'. In the piece, DDW Editor Reece Armstrong looks at the advantages and opportunities 3D cell cultures, organoids and stem cells are bringing to drug discovery teams.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week's leading story came from a positive development in biopharma, with top companies reporting market growth in Q3 of 2025. Elsewhere, new research could help combat yellow fever and weight loss, while £500,000 was awarded to a biotech company to develop a DMD therapy.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week's top story came from women's health, as Bayer paved the way for a new approach to treat hot flashes due to menopause. Elsewhere, an anti-obesity medication has health benefits beyond weight loss and Alector discontinued its dementia drug.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, Galapagos announced plans to shelve its cell therapy business and hundreds of employees are set to lose their jobs. Elsewhere, pharma firms are offering discounts to US patients and a new AI model shed light on how to improve immunotherapy.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, new research showed drug therapies could prevent hereditary diseases. Elsewhere, there were major developments in cancer research and gene therapy could help combat hearing loss.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Overcoming barriers to patient access", which covers two articles written for DDW Volume 25 – Issue 1, Winter 2023/24. They are called: "Scaling up: The need for human cells to give better access to cell therapies" and "Decentralised identities: Blockchain based informed consent."

In the first article, DDW Editor Reece Armstrong speaks to Kathryn Golden, SVP Technical Operations and Manufacturing at bit.bio. They discuss novel technologies, and methods to manufacture human cells for therapies so more patients can access these treatments.

In the second article, industry experts explain how blockchain can fundamentally enhance clinical trials.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news.

Last week, the Nobel Prize for Physiology or Medicine was awarded to three scientists for their discovery on regulatory T cells. Elsewhere, AI use continues to rise in pharma and biotech, while CAR-T therapy has been used for the first time to treat ulcerative colitis.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

DDW's Bruno Quinney narrates key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week's news is led by the agreement by Genmab to acquire Merus, an announcement which could have important ramifications in cancer research. Scientists have also made breakthroughs in pancreatic cancer, as well as in the understanding of Covid 'brain fog'.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Thibaud Portal, Founder and COO of Alys Pharmaceuticals, a biotech launched in 2024 with a landmark $100 million seed round. The conversation explores the vision behind founding Alys, the role of strategic collaborations with leading scientists, and the rationale for building a diversified dermatology pipeline spanning atopic dermatitis, systemic mastocytosis, and rare conditions such as Cold Urticaria.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

In this week's news, results from a clinical trial offer hope for the first time that Huntington's disease can be slowed. Elsewhere, new synthetic kidneys could be 'revolutionary' tools for kidney disease research, and pharma giant Merck has partnered with technology company Siemens to develop AI projects.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW's Bruno Quinney narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

In this week's news, AstraZeneca has halted its £200 million research investment in the UK. Elsewhere, the US Food and Drug Administration (FDA) has fast-tracked a gene therapy, CAR-T therapy could be an effective cancer treatment, and the National Institute for Health and Care Excellence (NICE) has updated its thresholds for ultra-rare disease drugs.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Emma Johnson, CEO of Essential Pharma, about the company's move into clinical development, with the acquisition of Renaissance Pharma's immunotherapy asset in development for the treatment of high-risk neuroblastoma in children.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Joel Stanley, CEO of Ajna Biosciences. We explore the promise and challenges of botanical drugs, focusing on Ajna Biosciences' approach to developing therapeutics derived from plants such as cannabinoids and psychedelics. Joel reflects on his experience co-founding Charlotte's Web during the early medical cannabis movement and how that shaped his perspective on botanical drug development.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

The news this week has emphasised the importance of shared knowledge and expertise to the development of new drugs, whether that is through research collaboration agreements or mergers and acquisitions, with a number of new deals across different therapy areas.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Strategies and challenges in therapeutic development and lab practice", which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: "The inner workings of antibiotics", "Targeting advances in immunotherapies", and "The considerations for building sustainable labs in pharma".

In the first article, Dr Luke Clifton, Instrument Scientist at ISIS Neutron and Muon Source, explains the molecular mechanism behind antibiotics.

In the second article, DDW Editor Reece Armstrong speaks to Christian Leisner, Chief Executive Officer of antibody therapeutics' developer CDR-Life about methods to increase access to antigens and improving immunotherapy treatments.

In the third article, DDW Editor Reece Armstrong speaks to Will Fogden, UK Development Manager, Kadans Science Partner, about sustainable efforts in pharma and the considerations industry needs to take into account when developing sustainable buildings.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

This week has seen some incredible advances in immunotherapy, including the development of a therapy that combines natural killer and CAR-T cells, and an off-the-shelf cancer vaccine that could revolutionise treatment for patients with one of the most common cancer-driving mutations.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

In the week that the US Department of Health and Human Services cancelled multiple contracts investigating mRNA vaccines, a number of other clinical trials have made the headlines.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Steve Ruston, CEO of Persica Pharmaceuticals. Ruston has been CEO since the company was founded and has been a key player in developing Persica's non-opioid, one-off treatment. In this episode, we discuss the shift toward treating bacterial causes of chronic low back pain, the use of MRI biomarkers in trials, the evolving role of non-opioid therapies amid the opioid crisis, and how Persica's scientific insights and early trial success could drive renewed investment in a historically challenging field.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

With the Alzheimer's Association International Conference (AAIC) taking place this week in Toronto, Canada, there have been a number of updates in the neuroscience drug discovery field.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

Following the recent news that the FDA rejected Ultragenyx Pharmaceutical's gene therapy due to manufacturing concerns, manufacturing has dominated the headlines this week, particularly significant investment in facilities in the US, and new guidelines to speed up CGT production in the UK.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Thijs Spoor, CEO of the radiopharma company Perspective Therapeutics. The conversation covers how Perspective is advancing alpha-emitting radiopharmaceuticals to transform cancer treatment, with Spoor discussing the scientific, regulatory, and commercial challenges shaping the future of personalised oncology.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

This week's news highlights reflect the incredible levels of innovation and investment, but also the hurdles to overcome, in developing gene therapies – breakthrough treatments in many genetic diseases that can bring their own unique challenges in terms of manufacturing, delivery and safety risks.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Innovative applications of AI in drug discovery", which covers two articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: "Decoding diseases: The AI renaissance in clinical trials" and "Advancing antibody discovery with AI".

In the first article, Deepika Khedekar, Associate Centralized Clinical Lead at IQVIA, explains how artificial intelligence could make clinical trials more accurate, accessible and standardised.

In the second article, DDW Editor Reece Armstrong, speaks to Kashif Sadiq, Founder of DenovAI Biotech about the importance of computational methods in this field.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

This week our news highlights focus on the drug discovery in the European Union, including some new regulatory approvals from the European Commission, advancements from Netherlands-based argenx, a new PhD programme in Estonia, and Switzerland's evolution as a deep tech leader.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

In significant news this week, the FDA in the US has removed red tape that limits which centres could give CAR-T therapy, in a move to improve access to the therapies. The round-up this time focuses on other developments in cell and gene therapies (CGT) including two high profile acquisitions.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "UK Spotlight: Innovation and discovery", which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: "Where is the drug discovery expertise happening in the UK?", "From the top: Dr Martin Main, Medicines Discovery Catapult", and "Meet the Researcher: Molly Stevens, Oxford University and Imperial".

In the first article, I highlight the research taking place and where this is happening in the UK, a long-established hub for drug discovery expertise worldwide.

In the second article, I spoke with Dr Martin Main, Chief Scientific Officer, Medicines Discovery Catapult, in the From the Top series.

In the third article, I spoke with Molly Stevens, John Black Professor at Oxford University and Research Director for Biomedical Materials at Imperial College London, as part of the Meet the Researcher series.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

As we announce the DDW 'Creating cures' programme at SLAS2026, the week's news highlights emphasise the importance of advanced technologies to the success of drug discovery, including digital control arms for clinical studies, nanobody-based imaging, and new applications for artificial intelligence (AI).

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Professor Jonathan Kagan, a Harvard immunology professor and director of Basic Research at Boston Children's Hospital. He's also the founder of Corner Therapeutics, a biotech startup launched this year with $54 million in funding to develop revolutionary vaccines designed to tackle a virtually unlimited range of diseases, including cancer, HIV, and Covid.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

In the same week DDW shared expert insights from the 2025 ASCO annual meeting, there have been several significant developments in oncology drug discovery, including new therapy options for some difficult to treat cancers.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

This week's round-up highlights the vital role of genetics in drug discovery, including new data for an Alzheimer's gene therapy, the discovery of a genetic target for rejuvenation therapies, and a 13-year follow up on haemophilia gene therapy patients.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Innovative uses for biomarkers in drug discovery", which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: "Advances in neuroscience drug discovery", "Putting human data at the centre of drug discovery", and "The era of precision neuroscience".

In the first article, Lu Rahman looks at neuroscience drug discovery – advances and challenges – and how breakthroughs in this field are helping address areas of unmet need.

In the second article, James Peach, Co-Founder and CEO of Human Centric Drug Discovery (HCDD), an Oxford University spin-out improving neurology drug discovery by bringing more human data to the process, shares insight with me.

In the third article, Dr Steve Gardner, CEO of the computational biology company PrecisionLife, explores the challenges of achieving precision medicine in complex CNS conditions and explains how new precision neuroscience approaches are benefitting pharmaceutical companies who are again investing in the field to develop better treatments for neurological and neuropsychiatric diseases.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

With conference season in full swing and the speakers announced for DDW's Turning Science into Business Symposium in November, our news round-up shines a light on the importance of these in-person events for sharing and discovering the latest drug discovery breakthroughs.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Dr Emil Lou, Professor of Hematology and Oncology at the University of Minnesota. They discuss the promising results of a recent clinical trial he led focused on gastrointestinal cancers, the potential impact of continued clinical success on the future of these hard-to-treat cancers, and the key challenges that must be addressed to sustain progress. Dr Lou also explores the evolving role of multiplexed gene editing in tackling immunosuppressive or heterogeneous solid tumours, the complexities of forging academia-industry partnerships to support early-phase innovation, and the scientific breakthroughs he believes will shape the next five years in cancer research.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

News stories of note for this week include a major deal signed between Eli Lilly and Rznomics in the field of RNA-editing therapies, and a potential quality-of-life breakthrough for patients with Parkinson's.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Innovative uses for biomarkers in drug discovery", which covers two articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: "How biomarkers can help discover new treatments for women's health" and "Could NfL accelerate drug development for neurodegenerative diseases?"

In the first article, DDW Editor Reece Armstrong speaks to Dr Steve Gardner, Co-Founder and CEO of PrecisionLife about work the company is doing to improve our understanding of endometriosis.

In the second article, Professor Andy Whiting and Dr Tony Lockett discuss how specific levels of a protein could be used to advance drug development in neurodegenerative diseases.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

Our news highlights this week focus on drug discovery for metabolic diseases, with a number of developments in treatments for obesity, liver disease, and diabetes.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Phil L'Huillier, CEO of Scancell. Following the company's recent partnership with the NHS Cancer Vaccine Launch Pad, enabling fast-tracked access for melanoma patients, we discuss how Scancell is addressing the scientific, clinical, and logistical challenges of developing therapeutic cancer vaccines—from overcoming tumour heterogeneity and improving immune response to leveraging national infrastructure like the NHS Cancer Vaccine Launch Pad to enable broader, more inclusive trial access.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

Our news highlights this time focus on two major regulatory agencies, in a week that saw the European Commission (EC) launch a new fund designed to tempt US researchers to EU countries, and the US Food and Drugs Administration (FDA) roll out extensive new AI systems.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Cutting-edge tools shaping early-stage drug discovery", which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: "The use-case for NGS", "Are organ-chips the future of preclinical research?" and "What spatial biology can tell us about disease and drug discovery".

In the first article, DDW Editor Reece Armstrong speaks to Dr Darrell Green, Lecturer in RNA Biology, Biomedical Research Centre, Norwich Medical School University of East Anglia, about his work using next generation sequencing (NGS) and the areas the technology is impacting within drug discovery and development.

In the second article, Diana Spencer catches up with Lorna Ewart, PhD, Chief Scientific Officer of Emulate, about the rise of organ-on-a-chip technology.

In the third article, DDW Editor Reece Armstrong speaks to Benedikt Nilges, Head of Technology and Data Analytics at OMAPiX about spatial biology's use in drug discovery and bettering our understanding of disease.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

Our highlights this week demonstrate a variety of approaches to cancer treatment, including a BTK inhibitor, macrophage checkpoint inhibitor, and antibody-drug conjugates, at various stages of development.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

In theIn Conversation Withseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this episode, Megan Thomas is in conversation with Dimitrios Goundis, CEO of Kither Biotech. Kither is a Phase I, soon to be Phase II, Italian biotech focused on respiratory diseases such as cystic fibrosis. This episode explores how emerging biotech strategies are advancing treatments for respiratory diseases like cystic fibrosis, with a focus on targeted drug delivery, clinical trial progression, and the evolving biotech landscape in Europe.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

The latest episode of the DDW Highlights podcast is now available. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

With the American Association of Cancer Research (AACR) Annual Meeting taking place from 25-30 April, the DDW news desk has been inundated with the latest advances in cancer drug discovery, so here are a few highlights. Check out our round-up for the event for more updates.

You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "An overview on the impact of synthetic biology", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "Synthetic biology: Impacting drug discovery" and "Synthetic biology: Innovating in drug discovery"

In the first article, Mark Kotter, Founder and CEO of bit.bio, talks with Reece Armstrong about different approaches to synthetic biology and its applications in programming stem cells into mature, functional human cells for drug discovery and the creation of next generation.

In the second article, Reece Armstrong examines recent activity within the synthetic biology sector and highlights some of the key advancements and innovation.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

With Eli Lilly so far winning the race to bring an oral GLP-1 drug to market, having announced positive topline results from a Phase III trial, this week our news highlights focus on clinical studies.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Where are scientists making waves in drug discovery?", which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "How pharma is targeting advances in Alzheimer's treatments", "The start-up disrupting the field of women's reproductive health" and "India: Why is the country ramping up drug discovery research?"

Cognition Therapeutics recently completed the enrolment of its Phase II SEQUEL trial for patients with mild-to-moderate Alzheimer's disease. The focus of the trial is to test Cognition Therapeutics' experimental drug, CT1812 for patients with dementia with Lewy Bodies and dry age-related macular degeneration. In the first article, Reece Armstrong speaks to Lisa Ricciardi, CEO of Cognition Therapeutics, to learn about what the company hopes to achieve with CT1812.

In the second article, DDW's Diana Spencer speaks to Alok Javali, CSO of dawn-bio, a new addition to BioInnovation Institute's (BII) Venture Lab acceleration programme, about the lack of innovation in women's reproductive health and the company's plans to fill the vacuum.

In the third article, I take a deeper look into why India is ramping up drug discovery research, and explores the country's innovation hubs of interest.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Innovation enabled by new drug discovery technologies", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "Accelerating biotherapy and personalised medicine with long DNA" and "The microbiome in precision medicine".

In the first article, Matt Hill, Founder and CEO of Elegen writes about the importance of innovation in DNA synthesis to address critical bottlenecks in biotherapy development.

In the second article, Katie Gillette, Senior Project Leader, Eliza French, Analyst, and Graham Friedman, Analyst, DeciBio, provide an industry overview of the role of the microbiome in precision medicine, and its interplay with research tools, diagnostics, and therapeutic development.

This is the latest episode of the free DDW narrated podcast, titled "Innovation enabled by new drug discovery technologies", which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "Sitting down with… Neil Dhawan", "Meet the researcher: Giusy Di Conza, iOnctura" and "From the Top: Adele Hannigan, Antibody Analytics".

In the first article, Reece Armstrong speaks to Neil Dhawan, the Co-founder and CEO of Totus Medicines about the company's approach to drug discovery using fundamental technologies in chemistry, biology and artificial intelligence (AI).

In the second article, Megan Thomas looked at a day in the life of Giusy Di Conza, Head of Research at iOnctura.

In the third article, Megan Thomas shines a spotlight on Adele Hannigan, CBO for Antibody Analytics, which has since been rebranded as RoukenBio.

This is the latest episode of the free DDW narrated podcast, titled "Innovation enabled by new drug discovery technologies", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "Finding the North Star of therapeutic antibodies" and "Which diseases will benefit from therapeutic antibody development?"

In the first article, Katie Abouzahr is the Vice President, Autoantibody Portfolio and Maternal Fetal Disease Area Leader at the Janssen Pharmaceutical Companies of Johnson & Johnson. She speaks with Megan Thomas about the future for Janssen's investigational medicine nipocalimab and antibody therapeutics at large.

In the second article, DDW's Megan Thomas looks at how different diseases will benefit from the success of therapeutic antibodies.

The latest episode of the DDW Highlights podcast is now available to listen. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

Weight loss drugs have been making the news this week. As we come to the end of Women's History Month, two of the covered studies focus on women's health, specifically the role of weight loss drugs in treating endometriosis and why women have worse side effects from these therapeutics.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Innovation enabled by new drug discovery technologies", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "CRISPR breakthroughs: New solutions for common diseases" and "Re-assessing the risks of drug-induced arrhythmias during drug discovery".

In the first article, Rolf Turk, Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies.

In the second article, Dr Mark Treherne, Dr Jack Scannell and Dr Richard Saumarez answer the question: Can potentially lethal arrhythmias induced by novel drugs be better predicted by using more relevant and sophisticated electrophysiological screening methods?

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

This week the DDW news round-up takes a look at developments in cancer research, including AZ's acquisition of EsoBiotec, positive trial results for an allogeneic T-cell therapy, and a new drug target for glioblastoma.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.

This is the latest episode of the free DDW narrated podcast, titled "Critical tools that support drug discovery and development", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "You think you need an ELN… but are you asking the right questions?" and "Big data: Charting a new path to drug discovery and development".

In the first article, Matt Clifford, Director of Research and Innovation Strategy at IDBS, discusses the questions that need to be asked if you're considering an ELN.

In the second article, Tim Lowery, President of JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.

Clinical trials of all stages have dominated the DDW news section this week. All the stories represent a significant step forward for drug discovery, either due to the innovative nature of the therapies being studied, or the unique methods employed in the trial.

You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.